Early Child Development and Nutrition in Guatemala
Professor, Department of Pediatrics, University of Maryland School of Medicine
1 other identifier
interventional
1,730
1 country
1
Brief Summary
Over 200 million children under the age of 5 years in low and middle-income countries do not reach their developmental potential, largely due to lack of adequate nutrients and lack of psychosocial stimulation. Stunting (length-for-age \< -2 z-scores) is an indication of chronic undernutrition. Guatemala has the high rates of stunting in the Western Hemisphere (over 40%). This trial examines the effect of providing a micronutrient powder manufactured in Guatemala vs. placebo and an early learning environment vs. no early learning environment on the growth, health, and development of young children in Guatemala.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2014
CompletedFirst Posted
Study publicly available on registry
November 27, 2014
CompletedStudy Start
First participant enrolled
February 16, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2015
CompletedAugust 16, 2019
August 1, 2019
10 months
October 31, 2014
August 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in cognitive, motor, social-emotional development from baseline to 12 months
Cognitive and social-emotional assessments
Baseline, 12 months
Secondary Outcomes (2)
Change in Growth from baseline to 12 months
Baseline, 12 months
Change in micronutrient status from baseline to 12 months
Baseline, 12 months
Study Arms (4)
Micronutrients No responsive feeding
EXPERIMENTALMicronutrient powder and no responsive feeding
Placebo and Responsive Feeding
PLACEBO COMPARATORPlacebo (vitamin B2) and Responsive Feeding
Micronutrients and Responsive caregiving
EXPERIMENTALMicronutrients and Responsive feeding intervention
Placebo and No responsive caregiving
PLACEBO COMPARATORPlacebo and No responsive caregiving
Interventions
Nutrient Quantity Nutrient Quantity Zinc 9 mg Copper 0.3 mg Iron 12.5 mg Vitamin D3 5 mg Folic Acid 160 mcg Vitamin E 5 mg Iodine 90 mcg Calcium 200 mg Vitamin A 250 mg Phosphorus 150 mg Vitamin C 40 mg Magnesium 40 mg Vitamin B12 0.9 mcg Selenium 17 mcg Thiamine 0.5 mg Manganese 0.17 mg Niacin 0.5 mg Biotin 8 mg Riboflavin 6 mg Vitamin B5 1.8 mg Vitamin B6 0.5 mg
Strategy Mother ensures that feeding area is set up with infant and mother able to see one another. Mother mirrors the infant's facial expressions to attract the infant's attention. Mother interprets infant's behavior with a positive voice, "Oh, you like the spinach." Mother extends infant's behavior by saying, "Oh the cereal is all gone" and doing a consistent hand signal Mother models eating, makes positive comments in a nurturing tone. Mother offers finger food or use of utensil
Riboflavin Vitamin B2
Eligibility Criteria
You may qualify if:
- Child speaks Spanish.
- Child is age 6-12 months or age 36-48 months.
- Child must be undernourished (length and height for age \< -1 z-score).
- Child does not have any obvious health or developmental problems that would interfere with growth, nutrition, or development.
- Child will remain in the area for the subsequent year.
- Parent or legal guardian of the child is age 18 years or older.
- Parent or legal guardian speaks and understands Spanish.
- Parent or legal guardian lives with child in study community.
You may not qualify if:
- Child is not age 6-12 months or 36-48 months.
- Child has severe stunting (length and height for age \< -3 z-scores).
- Child has identified conditions that could interfere with their development and growth.
- Child is severely anemic (hemoglobin \< 7).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
APEVIHS (Association for the Prevention and Study of HIV/AIDS)
Retalhuleu, Guatemala
Related Publications (1)
Unable to connect to PubMed to validate , last attempt on November 19, 2014 at 3:47 PM EST
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maureen M Black, Ph.D.
Uniersity of Maryland, Baltimore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 31, 2014
First Posted
November 27, 2014
Study Start
February 16, 2015
Primary Completion
December 8, 2015
Study Completion
December 8, 2015
Last Updated
August 16, 2019
Record last verified: 2019-08